← FDA Drug Approvals (Drugs@FDA)
RISVAN
NDA · New Drug Application · Sponsor: LABS FARMS ROVI SA · Approved 2024-03-29
Drug application
- FDA Application #
NDA214835
- Application type
- New Drug Application
- Brand name
- RISVAN
- Generic name
- Risperidone
- Active ingredients
- RISPERIDONE
- Dosage form
- FOR SUSPENSION, EXTENDED RELEASE
- Route
- INTRAMUSCULAR
- Marketing status
- Discontinued
- Sponsor
- LABS FARMS ROVI SA
- First approval
- 2024-03-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown